Molds - Mold Mix 4
Generic Name: molds - mold mix 4
Brand Names:
Molds - Mold Mix 4
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ALTERNARIA ALTERNATA (.1 g/mL); ASPERGILLUS FUMIGATUS (.025 g/mL); ASPERGILLUS NIDULANS (.025 g/mL); ASPERGILLUS NIGER VAR. NIGER (.025 g/mL); ASPERGILLUS TERREUS (.025 g/mL); CLADOSPORIUM CLADOSPORIOIDES (.1 g/mL); CLONOSTACHYS ROSEA F. ROSEA (.025 g/mL); PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (.025 g/mL); PENICILLIUM DIGITATUM (.025 g/mL); PENICILLIUM EXPANSUM (.05 g/mL). Category: BLA.
Overview
Dosage form: INJECTION, SOLUTION. Route: PERCUTANEOUS. Active ingredients: ALTERNARIA ALTERNATA (.1 g/mL); ASPERGILLUS FUMIGATUS (.025 g/mL); ASPERGILLUS NIDULANS (.025 g/mL); ASPERGILLUS NIGER VAR. NIGER (.025 g/mL); ASPERGILLUS TERREUS (.025 g/mL); CLADOSPORIUM CLADOSPORIOIDES (.1 g/mL); CLONOSTACHYS ROSEA F. ROSEA (.025 g/mL); PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM (.025 g/mL); PENICILLIUM DIGITATUM (.025 g/mL); PENICILLIUM EXPANSUM (.05 g/mL). Category: BLA.
Dosage
Available as injection, solution for percutaneous use.
Related Medications
Ranibizumab-eqrn
ranibizumab-eqrn
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION Ranibizumab-eqrn is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab-eqrn binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab-eqrn, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system.
Compressed Oxygen
compressed oxygen
Capsaicin 0.025%, Menthol 10%, Methyl Nicotinate 0.25%, Methyl Salicylate 10%
capsaicin 0.025%, menthol 10%, methyl nicotinate 0.25%, methyl salicylate 10%
Purpose Counterirritant Counterirritant Counterirritant Counterirritant
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.